HLA-B13

HLA-B13 (B13) is an HLA-B serotype. The serotype identifies the more common HLA-B*13 gene products.[1] (For terminology help see: HLA-serotype tutorial)

major histocompatibility complex (human), class I, B13
Alleles B*1301, *1302
Structure (See HLA-B)
Symbol(s) HLA-B
EBI-HLA B*1301
EBI-HLA B*1302
Locus chr.6 6p21.31

Serotype

B13 serotype recognition of Some HLA B*13 allele-group gene products[2]
B*13B13 Sample
allele%%size (N)
130197238
1302991307

Allele frequencies

HLA B*1301 frequencies
freq
ref.Population(%)
[3]Papua New Guinea Wosera28.3
Australian Aborigine Cape York Peninsula27.0
Taiwan Bunun26.7
Australian Aborigine Groote Eylandt23.3
Taiwan Thao21.7
Taiwan Tsou17.6
India Khandesh Pawra12.0
China South Han8.2
New Caledonia7.7
South Africa Natal Tamil6.1
Philippines Ivatan6.0
Papua New Guinea Eastern Highlands Goroka5.7
Singapore Riau Malay5.4
China North Han4.8
Thailand4.1
India West Coast Parsis3.0
India North Hindus2.9
Jordan Amman2.1
South Korea (3)2.1
Thailand2.1
China Inner Mongolia2.0
France South East1.9
Georgia Tibilisi Kurds1.7
Japan Central1.5
India Andhra Pradesh Golla1.4
India North Delhi1.1
[3]B*1302
India West Coast Parsis16.0
Cameroon Bakola Pygmy7.0
Czech Republic6.6
Georgia Svaneti Svans6.3
Georgia Tibilisi Georgians5.6
India Mumbai Marathas4.3
Romanian4.1
India West Bhils4.0
China North Han3.8
Sudanese3.8
South Korea pop 33.5
Georgia Tibilisi Kurds3.4
Russia Tuva pop 23.3
Israel Arab Druse3.0
Central Africa Republic Mbenzele Pygmy2.8
Israel Ashkenazi and Non Ashkenazi Jews2.8
Uganda Kampala2.8
Bulgaria2.7
Cameroon Yaounde2.7
Guinea Bissau2.3
Kenya Nandi2.3
India North Delhi2.2
Zimbabwe Harare Shona2.2
Kenya2.1
Croatia2.0
Cameroon Bamileke1.9
USA North American Natives1.9
China South Han1.8
Finland1.7
Belgium1.5
South African Natal Zulu1.5
Tunisia1.5
India Andhra Pradesh Golla1.4
Azores Santa Maria and Sao Miguel1.3
Ireland South1.2
Singapore Chinese Han1.2
Kenya Luo1.1
Mexico Chihuahua State Tarahumara1.1
Tunisia Tunis1.1
Zambia Lusaka1.1
Portugal Centre1.0
Saudi Arabia Guraiat and Hail1.0
Singapore Javanese Indonesians1.0
gollark: But you *can* be blind to it in some contexts by structuring things so you don't actually know it.
gollark: Well, for conference organization, probably just do the decision about whether to have a panel or not (is that how this works) without the reviewers knowing stuff about the speaker.
gollark: Not just paying *more* attention to it.
gollark: Designing systems which are blind to this sort of trait entirely.
gollark: I don't really agree with "fixing" discrimination by just discriminating more in a different direction.

References

  1. Marsh, S. G.; Albert, E. D.; Bodmer, W. F.; Bontrop, R. E.; Dupont, B.; Erlich, H. A.; Fernández-Viña, M.; Geraghty, D. E.; Holdsworth, R.; Hurley, C. K.; Lau, M.; Lee, K. W.; Mach, B.; Maiers, M.; Mayr, W. R.; Müller, C. R.; Parham, P.; Petersdorf, E. W.; Sasazuki, T.; Strominger, J. L.; Svejgaard, A.; Terasaki, P. I.; Tiercy, J. M.; Trowsdale, J. (2010). "Nomenclature for factors of the HLA system, 2010". Tissue Antigens. 75 (4): 291–455. doi:10.1111/j.1399-0039.2010.01466.x. PMC 2848993. PMID 20356336.
  2. derived from IMGT/HLA
  3. Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database: http://www.allelefrequencies.net". Tissue Antigens. 61 (5): 403–7. doi:10.1034/j.1399-0039.2003.00062.x. PMID 12753660. External link in |title= (help)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.